Search Within

Genitourinary Oncology Service

  1. "Alumni (GSK)"
Formats
  1. Journal Article (69)
  2. Meeting Abstract (38)
  3. Editorial (2)
  4. Book Section (1)
  5. Correspondence (1)
Groups
  1. Alumni (GSK) (111)
  2. Department of Medicine (111)
  3. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (111)
  4. Solid Tumor Oncology Division (111)
  5. GSK Faculty (108)
  6. Human Oncology and Pathogenesis Program (99)

More Groups

People
  1. David Solit (50)
  2. Michael Berger (43)
  3. Yu Chen (32)
  4. Marc Ladanyi (30)
  5. Nikolaus Schultz (27)
  6. Ping Chi (26)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (15)
  5. 2021 (13)
  6. 2020 (16)

More Years

Publications
  1. Cancer Research (21)
  2. Journal of Clinical Oncology (13)
  3. Cancer Discovery (9)
  4. Clinical Cancer Research (8)
  5. Cancer Cell (5)
  6. Nature (5)

More Publications

Publishers
  1. American Association for Cancer Research (41)
  2. American Society of Clinical Oncology (18)
  3. Nature Publishing Group (15)
  4. Cell Press (10)
  5. American Medical Association (4)
  6. American Society for Clinical Investigation (3)

More Publishers

Results (111)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pragmatic use of minimal common oncology data elements and observational medical outcomes partnership at an academic medical center
    Editorial

    Sandler, T.; Manglicmot, S.; Mullen, K. M.; Shah, N.; Philip, J.
    JCO Clinical Cancer Informatics (2025)

    Fulltext@MSK | Save
  • ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L
    Journal Article

    Feng, W.; Ladewig, E.; Lange, M.; Salsabeel, N.; Zhao, H.; Lee, Y. S.; Gopalan, A.; Luo, H.; Kang, W.; Fan, N.; more...
    Nature Genetics (2025)

    Fulltext@MSK | Save
  • Genetic ancestry-based differences in biomarker-based eligibility for precision oncology therapies
    Journal Article

    Arora, K.; Suehnholz, S. P.; Zhang, H.; Ostrovnaya, I.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Brannon, A. R.; Bandlamudi, C.; Ladanyi, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
    Journal Article

    Mao, N.; Lee, Y. S.; Salsabeel, N.; Zhang, Z.; Li, D.; Kaur, H.; Chen, X.; Chang, Q.; Mehta, S.; Barnes, J.; more...
    Science Advances (2025)

    Fulltext@MSK | Save
  • SAABR: Single arm phase II study of androgen receptor pathway inhibitor (ARPI) + atezolizumab + GnRH analog (ADT) and stereotactic body radiotherapy (SBRT) to the prostate in men with de novo hormone-sensitive metastatic prostate cancer (mHSPC)
    Meeting Abstract

    Rathkopf, D.; Dallos, M.; Stein, M.; Spina, C. S.; Deutsch, I.; Nguyen, C.; Okada, A.; Lloyd, M.; Manarite, J.; McBride, S.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • OncoKB: Automated somatic variant classification for rapid clinical decision making
    Meeting Abstract

    Suehnholz, S.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Cavender, K.; Preiser, B.; Konecny, J.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • MEK inhibitors lead to PDGFR pathway upregulation and sensitize tumors to RAF dimer inhibitors in NF1-deficient malignant peripheral nerve sheath tumor
    Journal Article

    Miranda-Román, M. A.; Lee, C. J.; Fishinevich, E.; Ran, L.; Patel, A. J.; Yan, J.; Khudoynazarova, M. N.; Warda, S.; Pachai, M. R.; Chen, Y.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tracking the FDA precision oncology drug approval landscape in OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save